XML 13 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover - shares
6 Months Ended
Dec. 31, 2023
Feb. 20, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --06-30  
Entity File Number 000-55320  
Entity Registrant Name NEXIEN BIOPHARMA, INC.  
Entity Central Index Key 0001625288  
Entity Tax Identification Number 26-2049376  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 4340 E Kentucky Ave.  
Entity Address, Address Line Two Suite 206  
Entity Address, City or Town Glendale  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80246  
City Area Code (303)  
Local Phone Number 495-7583  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   67,472,196